Eli Lilly
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Eli Lilly and other ETFs, options, and stocks.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
LLY News
Playing Now Stocks Pause After Recent Run; Star Bulk Carriers, Ares Management, Embraer In Focus 15:04 Market Indexes Clear Another Hurdle; Tradeweb, NetApp, Q...
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. Think a friend or colleague should be getti...
Loading... Loading... Tuesday, the FDA said it would convene an in-person meeting of the Peripheral and Central Nervous System Drugs Advisory Committee on Mond...
Analyst ratings
70%
of 30 ratingsMore LLY News
In this article AMGN LLY NOVO.B-DK Follow your favorite stocks CREATE FREE ACCOUNT The injectable weight-loss medication Wegovy is available at New City Hals...
The IBD Stock Screener quickly scans thousands of stocks to identify those with great fundamentals and bullish charts. Today's screen highlights stocks that mut...
The largest pharmaceutical company in the world by market cap, Eli Lilly (NYSE: LLY), is continuing to share some of its profits with shareholders. The company...
Loading... Loading... Eli Lilly and Co LLY has outperformed the market over the past 15 years by 10.37% on an annualized basis producing an average annual retu...
Eli Lilly (NYSE:LLY) First Quarter 2024 Results Key Financial Results Revenue: US$8.77b (up 26% from 1Q 2023). Net income: US$2.24b (up 67% from 1Q 2023). P...
Loading... Loading... Deep-pocketed investors have adopted a bullish approach towards Eli Lilly and Co LLY, and it's something market players shouldn't ignore....
INDIANAPOLIS, May 6, 2024 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2024 of...